Clovis revenue drops 11% in first quarter
BOULDER — Clovis Oncology Inc. (NYSE: CLVS) posted declining revenue for the first quarter of 2021, with $38.1 million in […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Bankrupt Clovis faces delisting from Nasdaq
BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS), which filed for Chapter 11 bankruptcy protection Dec. 11, has received a delisting…
Clovis Oncology files Chapter 11, agrees to sell a drug asset
BOULDER and WILMINGTON, Delaware — Boulder-based Clovis Oncology Inc. (Nasdaq: CLVS) filed for Chapter 11 bankruptcy protection Sunday. Its filing…
Clovis defaults on loan, expects to file Chapter 11
BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) has defaulted on a loan agreement and expects to file for Chapter 11…